Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT6010 versus pregabalin versus placebo for peripheral neuropathic pain
2011-002092-42Phase 2Completed
- Sponsor
- Grünenthal GmbH
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Peripheral neuropathic pain, postherpetic neuralgia (PHN), Neuralgia and 1 more comparing GRT6010, Pregabalin and Placebo (3 arms). Primary endpoint: Change in ongoing pain intensity versus placebo. Started Aug 2011; status: completed.
02
Drugs
GRT6010pregabalin
03
Conditions
Peripheral neuropathic painpostherpetic neuralgia (PHN)Neuralgiaperipheral nerve injury (PNI)
Beyond the preview
Go deeper on 2011-002092-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002092-42.